FDA Flu Vaccine Inspections Need More Compressed Timeframe – Rep. Davis
Executive Summary
FDA's procedures for inspecting flu vaccine manufacturing facilities may need revision in light of the current supply shortage, House Government Reform Committee Chairman Tom Davis (R-Va.) suggested during a Nov. 17 hearing
You may also be interested in...
FDA Warning Letters Decline, But Agency Says Enforcement Is Still Strong
A report issued by a leading House Democrat shows that the number of warning letters issued by FDA dropped more than 50% over the last five years, but FDA staffers say the figures don't necessarily mean the agency has grown lax in its enforcement
FDA Warning Letters Decline, But Agency Says Enforcement Is Still Strong
A report issued by a leading House Democrat shows that the number of warning letters issued by FDA dropped more than 50% over the last five years, but FDA staffers say the figures don't necessarily mean the agency has grown lax in its enforcement
FDA To Determine Flu Vaccine Suppliers For 2005-2006 Season In January
FDA will decide whether Chiron can produce flu vaccine for next season by Jan. 5, Acting Commissioner Lester Crawford, PhD, said Nov. 18